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Background
Neonatal hypoglycemia is a common metabolic 
abnormality in newborns due to inability to maintain 
glucose homeostasis [1,2]. Glucose is an essential primary 
substrate for the brain and its consumption by the brain is 
high and as a result, neurons and glial cells are susceptible 
to hypoglycemia [3,4]. Therefore, glucose homeostasis is 
crucial for the overall physical development of newborns 
[5]. Throughout gestation, maternal glucose provides all 
the glucose for the fetus via facilitated diffusion across 
the placenta according to a maternal-to-fetal glucose 
concentration gradient [5]. Hypoglycemia was defined 
by studies as early as 1937 as “mild” (2.2–3.3 mmol/l), 
“moderate” (1.1–2.2 mmol/l), and “severe” (<1.1 
mmol/l) [6]. A specific blood glucose concentration to 
define neonatal hypoglycemia for infants is a subject of 
controversy [7-10]. However, it is generally accepted that 
neonatal hypoglycemia is defined by a plasma glucose 
level of less than 30 mg/dl or 1.65 mmol/l in the first 24 
h of life [11]. To date, hypoglycemia remains one of the 
major metabolic abnormalities of the newborn [12-14].
The most common symptoms of neonatal hypoglycemia 
are shakiness, tachycardia, lethargy, and temperature 
irregularities [15,16]. In the presence of these symptoms, 
neonatal hypoglycemia is defined as capillary plasma 
glucose of less than 46 mg/dl (2.6 mmol/l) [15]. Prolonged 
neonatal hypoglycemia may also cause neuroglycopenic 
signs such as seizure, coma, cyanotic episodes, apnea, 
bradycardia or respiratory distress and hypothermia [4,17].
Several clinical conditions could be associated with 
neonatal stress that could affect glucose homeostasis of the 
newborn infant including infection, asphyxia, congenital 
heart disease, decreased substrate availability as a result 
of birth defects, prematurity and fetal growth restriction, 
islet cell hyperplasia, erythroblastosis fetalis, and 
Beckwith-Wiedemann Syndrome [4,18-22]. In addition, 
endocrine abnormalities such as pan-hypopituitarism, 
hypothyroidism, adrenal insufficiency, increased glucose 
utilization, sepsis and perinatal asphyxia could also be 
associated with neonatal hypoglycemia [17,18]. Although 
in most of these neonates, hypoglycemia is transient and 
asymptomatic, unrecognized hypoglycemia may lead to 
neonatal seizures, coma, and neurologic injury [15,23-26].
The risk of developing hypoglycemia among infants 
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born from diabetic mothers is even higher [27-34]. 
Hypoglycemia occurs in approximately 8-30% of neonates 
born to mothers with diabetes, with an estimated incidence 
rate of approximately 27% among infants born to women 
with diabetes compared to 3% among apparently healthy 
full-term infants born to non-diabetic women [35-38]. 
Although the predisposing risk factors for the development 
of neonatal hypoglycemia in diabetic pregnancies are 
thought to be mainly related to poor maternal glycemic 
control, neonatal weight at birth, and gestational age at 
delivery, the full extent of the individual and contextual 
risk factors remains unclear. In addition, to date, no 
systematic reviews of the available studies exist [39,40]. 
Our objective is to conduct a systematic review of the 
literature on the risk factors for hypoglycemia in infants 
of diabetic mothers. Accordingly, all relevant empirical 
studies on neonatal hypoglycemia in diabetic mothers 
were reviewed and appraised for methodological quality. 
The results were summarized in a way that informs both 
clinical practice and future research. 
Method
Search Strategy
We identified published studies using PubMed and 
EBSCOhost search engines. The search was carried out by 
using the population, intervention, control, and outcome 
(PICO) strategy. The following concepts and related key 
words searched in their respective PICO category and 
they were finally combined together: (1) neonatal terms 
(‘neonate, ‘neonates’, ‘neonatal’, ‘newborn’, ‘newborns’ 
and ‘infant’), (2) diabetes and pregnancies terms 
(‘pregnancy in diabetics’, ‘diabetic mothers’, ‘diabetic 
pregnancy’, ‘pregnancy in diabetes’) and outcome terms 
(‘hypoglycemia’, ‘hypoglycaemia’, ‘hypoglycemic’ and 
‘neonatal hypoglycemia’). We included all empirical 
studies published in the English language between 
January 1, 2000 and March 31, 2016. Additional studies 
were identified from reference lists of identified articles. 
The following inclusion and exclusion criteria were used 
to identify relevant articles:
Inclusion Criteria
(1) Observational studies, (2) neonatal hypoglycemia 
is used as the primary outcome of interest, (3) neonates 
born from type 1 (defined as blood glucose ≥ 11.1 
mmol/l), type 2 (defined as fasting blood glucose ≥ 7.0 
mmol/l or ≥ 11.1 mmol/l during OGTT) or gestational 
diabetic mothers (defined as having at least two plasma 
glucose measurements during the diagnostic test of the 
following OGTT glucose threshold values: 5.3 mmol/l 
fasting, 10.0 mmol/l at 1 h, 8.7 mmol/l at 2 h and 7.8 
mmol/l at 3 h), (4) has appropriate comparison group, (5) 
neonatal hypoglycemia diagnosed within 3 days of life, 
and outcome defined in the ranges of 20 to 50 mg/dl or 
1.1-2.8 mmol/l.
Exclusion Criteria
(1) Animal studies, (2) review articles, (3) articles 
published in non-English language, (4) articles 
published prior to 2000, and (5) poorly defined 
comparison group.
Data Abstraction and Overall Assessment of Studies 
The abstracts of all potential publications were reviewed 
initially by the first (B.A.) and the second (O.O.) authors 
to identify eligible publications for further review. Full 
text screening was made by the two authors through 
detailed review of the complete text of each article using 
the inclusion/exclusion criteria as a guideline. The two 
authors then independently reviewed publications that 
were identified for inclusion. Relevant study attributes 
were extracted from the selected publications using 
standardized forms developed for the systematic review 
project by the authors. A third author (M.A) mediated to 
resolve any disagreements between the authors. 
The STROBE (Strengthening the Reports of Observational 
Studies in Epidemiology) Statement (checklist of items 
that should be included in reports of observational studies) 
was used to assess studies’ strengths, weaknesses, and 
generalizability. An explanation and elaboration article that 
discusses each checklist item and gives methodological 
background and published examples of transparent 
reporting were used in conjunction with the STROBE 
checklist [41]. As most of the studies in this topic are 
observational, we used the STROBE checklist as a guide 
to systematically evaluate the studies that were included in 
this review. The STROBE checklist has 21 items with 15 
items relevant to all three study designs (i.e., cohort, case-
control, and cross-sectional studies) and 4 are specific for 
each. However, items 1-3 (background and objectives), 
6b (for matched studies), 11 (quantitative variables) and 
22 (funding information) were removed as they were not 
applicable to the included studies. Therefore, a modified 
15-item STROBE checklist was used to critically appraise 
study quality for this systematic review.
Results 
Study Selection
A total of 1233 titles were identified on PubMed and 
EBSCOhost in the initial literature search, 1202 of which 
were excluded by the first screening based on the title or 
abstract, leaving 31 articles for full-text review (Figure 
1). Thirteen of these studies met the inclusion criteria and 
an additional 3 articles were included from references 
listed these articles, resulting in 16 eligible studies, most 
of which were based on observational studies (Table 1) 
[27,35,41]. The main reasons for excluding studies after 
full review were (i) hypoglycemia was not listed as primary 
outcome, (ii) comparison group were not defined and, (iii) 
hypoglycemia was not defined within the specified range 
of 1.7-2.8 mmol/l.
We identified four prospective cohorts, one nested case-
control and ten retrospective cohort studies that examined 
the various clinical risk factors for hypoglycemia in 
diabetic mothers. Mother’s diabetes types included 
Gestational Diabetes Mellitus (GDM), Type-1 Diabetes 
Mellitus (T1D) and type-2 diabetes mellitus (T2D). Other 
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Table 1. Description of included neonatal hypoglycemia studies
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details on included studies are summarized in Table 1. A 
total of 13,248 infants were identified in the 16 included 
studies. The key findings are described in the following 
section (Table 2).
Critical Appraisal
The two authors agreed initially on 228 out of 250 
(95%) items on the modified STROBE checklist. All 
disagreements were resolved by discussion among the 
two reviewers. Overall, the quality scores of the included 
studies ranged from 26.66% to 86.66%, with a median of 
46.66%. Included studies were classified as high quality 
if the individual quality scores were ≥ 80%; studies were 
classified as moderate quality for quality scores between 
80% and 59% and studies with quality scores below 
60% was classified as low quality. Accordingly, a total 
of five high quality, two moderate quality and nine low 
quality studies were identified [11,16,20,22,28-39]. The 
individual item, assessment responses, and quality scores 
can be found in Table 3.
Clinical Significance and Risk Factors of Neonatal 
Hypoglycemia 
Four prospective cohort studies examined various 
Flores-le 
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risk factors of hypoglycemia in neonates of women 
with different diabetes type [22,27,42,43]. Roux et al. 
[27] prospectively examined glucose levels in infants 
of women with GDM and the influence of maternal, 
gestational and peripartum factors on the development 
of hypoglycemia. They found that hypoglycemic infants 
were more frequently Large for Gestational Age (LGA) 
(29.3% vs. 11.3%), had lower umbilical cord pH (7.28 
vs. 7.31), and their mothers had more frequently been 
hyperglycemic during labor (18.8% vs. 8.5%). The study 
obtained data from infants born in a hospital to mothers 
with GDM over a period of 30 months. After adjusting for 
confounding factors, umbilical cord venous pH [odds ratio 
(OR): 0.04, 95% Confidence Interval (CI): 0.261–0.99)] 
and Pakistani origin patients (OR: 2.94; 95% CI: 1.14 
7.55) were significantly and independently associated with 
hypoglycemia. Similarly, Agrawal et al. [22] found that 
infants of mothers diagnosed with GDM or preexisting 
diabetes prior to 28 weeks gestation were at a higher 
risk of developing hypoglycemia compared to those with 
maternal diabetes diagnosed at 28 weeks gestation (OR: 
7.2, 95% CI: 1.3-40.7). However, there was no difference 
in the cord blood glucose levels between infants with or 
without hypoglycemia. 
Sarkar et al. [42] on the other hand, examined the risk 
of developing hypoglycemia in infants born to women 
with diet-controlled GDM (GDM-A1), insulin-requiring 
(GDM-A2) and Insulin-Dependent Diabetes (IDDM) at 
36 weeks of gestation compared to infants born to healthy 
controls using data obtained over a period of 16 months. 
They found that there is no significant difference in the 
incidence of hypoglycemia in infants born to GDM-A1 
(4.3%) compared to infants born to healthy controls 
(4.4%). They concluded that infants born to GDM Class 
A1 women at ≥ 36 weeks of gestation are not at increased 
risk of developing hypoglycemia. Cordero and Landon 
also found a 3% incidence of transient hypoglycemia in 
healthy full-term infants born to non-diabetic women 
[37,38]. 
Using national data from the Swedish Medical Birth 
Registry, Persson et al. [43] investigated whether 
disproportionate body composition is a risk factor for 
perinatal complications, including hypoglycemia, in 
LGA infants born to mothers with T1D. Their findings 
showed that there was no significant difference in the 
risk for hypoglycemia between proportionate LGA (OR: 
1.42, 95% CI: 1.01-2.0) and disproportionate LGA infants 
(OR: 1.42, 95% CI: 0.97-2.08) compared to Appropriate 
for Gestational Age (AGA). Disproportionate LGA 
was defined as Ponderal Index (PI)>90th centile and 
proportionate <90th centile LGA according to gestational 
age and sex (Table 2) [44-63] . Similar results were 
Figure 1: Selection process for including studies in the systematic review
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Authors (s). (Years) Main Results
Agrawal et al. 
(2000) [22]
Hypoglycemia in 18 (47%) infants developed during the first 2 h of life. There was no difference 
in the cord blood glucose levels between infants with or without hypoglycemia. Infants of 
mothers with diabetes diagnosed prior to 28 weeks gestation were at a higher risk of developing 
hypoglycemia (OR 7.2, 95% CI: 1.3–40.7). Hypoglycemic infants were of significantly higher 
birth weight (3681) compared to normal infants (3160). 
Majeed et al. (2011) 
[44]
There were 16 neonates who were hypoglycemic at delivery. The area under the Receiver Operator 
Characteristics (ROC) curve for predicting neonatal hypoglycemia was 0.997 with a 95% CI of 
0.992 to 1. The optimal threshold value for HbA1c in predicting NH was 6.8%.
Bollepalli et al. 
(2010) [56]
Asymmetric LGA infants had 3.5 (95% CI: 1.4, 8.7), 2.2 (95% CI: 1.2, 4.2) and 3.2 (95% CI: 1.7, 
5.9) fold greater odds of hypoglycemia, hyperbilirubinemia and composite morbidity, respectively, 
compared with symmetric non-LGA infants.
Ferrara et al. (2007) 
[55]
A total of 486 with infants with hypoglycemia, 488 with macrosomia, and with hyperbilirubinaemia 
were identified. Women with GDM by ADA criteria had an increased risk of having an infant 
with hypoglycemia (OR: 2.61, 95% CI: 0.99–6.92), macrosomia (3.40, 95% CI: 1.55–7.43) or 
hyperbilirubinaemia (2.22, 95% CI: 0.98–5.04) compared to healthy control infants.
Garcia-Patterson et 
al. (2012) [57] 
The rate of hypoglycaemia in neonates was 3% (63). Maternal pre-pregnancy BMI of 25 kg/m2 
was an independent predictor of hypoglycaemia irrespective of potential intermediate variables being 
included in the model (OR: 2.11, 95% CI: 1.10–4.03) or without (OR: 2.66, 95% CI: 1.44–4.92). 
Das et al. (2009) 
[58]
The incidence of hypoglycemia among IDMs was 56.1% compared to non-IDMs 28.6%. There 
was significantly more hypoglycemia among the group weighing >4500 g compared to the group 
weighing 4000–4499 g. Compared to IDMs, non-IDMs were born later (40 vs. 38 week), were 
more likely to be delivered vaginally (70% vs. 34%) and had a higher incidence of birth injury 
than IDMs (8% vs. 2.4%). 
Metzger et al. (2014) 
[35]
Among the neonates in the study group 29 (36.7%) had at least one hypoglycemia value of <47 
mg/dl and 8 (10.1%) had a value of <40 mg/dl in the first 8 h of life. After controlling confounding 
factors such as birth weight, delivery number, and grasp evaluation only lower cord blood glucose 
significantly predicted hypoglycemia for each decrease of 10 mg/dl (OR 2.11, 95% CI: 1.1–4.03).
Mitroviu et al. 
(2014) [59]
The incidence of neonatal hypoglycemia was 52% in mothers with Type 1 diabetes, and 16.5% in 
mothers with Type 2 diabetes or GDM. The incidence neonatal morbidities such as hypoglycemia, 
pathological jaundice, and other neonatal pathologies at birth, was statistically significantly higher 
and Apgar scores after 1 min and after 5 min were statistically significantly lower in the mothers 
with diabetes (type 1 and 2) compared to the healthy women.
Persson et al. (2012) 
[43]
Neonatal morbidities were significantly more frequent in LGA compared to AGA infants. The 
proportions of preterm births and girls were significantly higher in LGA infants (44% preterm and 
52% girls) compared with AGA infants (30% preterm and 47% girls) born to women with Type 
1 diabetes. The risks of hypoglycemia were comparable between P-LGA and D-LGA infants. No 
significant difference in risk was found between AGA and P-LGA and D-LAG.
Ramos et al. (2010) 
[15]
The incidence of hypoglycaemia was 18% (44/242). The incidence was significantly higher in 
those requiring pharmacotherapy (25% vs. 3%). The frequency of hypoglycaemia between the 
glyburide and insulin-treated pregnancies did not differ significantly (23% vs. 27%). The frequency 
of hypoglycaemia was statistically associated with birth weight, macrosomia and ponderal index. 
Ponderal index was the strongest predictor of hypoglycaemia (OR: 5.59, 95% CI: 1.34–23.25).
Flores-le Roux et al. 
(2012) [27]
A total of 23 (12.1%) mild, 20 (10.5%) moderate and 5 (2.6%) severe hypoglycemia were observed. 
Hypoglycemic infants were more frequently LGA (29.3% vs. 11.3%) had lower umbilical cord pH 
(7.28 vs. 7.31) and their mothers had more frequently been hyperglycemic during labor (18.8% 
vs. 8.5%). Pakistani origin (OR: 2.94; 95% CI: 1.14 7.55) and umbilical cord venous pH (OR: 
0.04, 95% CI: 0.261–0.99) were significantly and independently associated with hypoglycemia in 
multivariate analysis.
Ryan et al. (2012) 
[60]
The NH rate was 7.3% (4.9% in GDM mothers and 10.9% of mothers with pre-existing diabetes). 
The insulin-glucose infusion was used in 47% of women with T1D, T2D, and GDM requiring 
≥ 0.5 units/kg/day of insulin during pregnancy and in 8% of women with GDM treated by diet 
or <0.5 units/kg/day of insulin. The overall rate of maternal hypoglycaemia was low (6.6% with 
blood glucose ≤ 3.5 mmol/L and 1.5% ≤ 3.0 mmol/L) pre-delivery; 13.9% of women had a blood 
glucose level ≥ 7.0 mmol/L. Standardized management for diabetic women in labour using an 
intravenous insulin-glucose protocol was effective in achieving stable maternal blood glucose 
levels with low rates of neonatal hypoglycaemia.
Table 2. Results of included studies of hypoglycemic neonates born from diabetic mothers
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obtained by Leperque et al. [64] while Ballard et al. [65] 
and Bollepalli et al. [56] contrasted the result. In a nested 
case-control study, Ferrara et al. [29] found that women 
with GDM defined by American Diabetes Association 
(ADA) criteria had an increased risk of having an infant 
with hypoglycemia (OR: 2.61, 95% CI: 0.99–6.92), 
although not statistically significant. The study used 
a group practice database that included 16 hospitals 
and provides medical services to approximately 3.0 
million people. Their findings supported the ADA 2000 
recommendations (GDM, 2000) to adopt lower plasma 
glucose thresholds proposed by Carpenter and Coustan 
for the diagnosis of GDM [42].
We also identified ten retrospective cohort studies and 
one nested case-control study that examined the risk of 
developing hypoglycemia in infants born to mothers 
with different diabetic conditions [15,35,56-63]. Most of 
these observational studies were conducted using medical 
institution based databases. 
Garcia-Patterson et al. [57] examined the relationship 
between maternal pre-pregnancy BMI and hypoglycemia 
among infants born to women with GDM with a gestational 
age higher than 22 weeks using databases from a tertiary 
care center. Maternal pre-pregnancy BMI ≥ 25 kg/m2 was 
determined as an independent predictor of hypoglycemia 
irrespective of potential intermediate variables being 
included in the model (OR: 2.11, 95% CI: 1.10–4.03) 
or without (OR: 2.66, 95% CI: 1.44–4.92). The rate of 
hypoglycemia in neonates was 3% (63). On the other 
hand, Metzger et al. [35] examined the impact of duration 
of delivery room breastfeeding on blood glucose levels 
(BGL) during the first hours of life among term neonates 
born to mothers with GDM and to examine its relationship 
with hypoglycemia using a medical center database. 
Among the neonates in the study group, 29 (36.7%) had at 
least one hypoglycemia value of <47 mg/dl and 8 (10.1%) 
had a value of <40 mg/dl in the first 8 h of life. After 
controlling confounding factors such as birth weight, 
delivery number and grasp evaluation only lower cord 
blood glucose significantly predicted hypoglycemia for 
each decrease of 10 mg/dl (OR 2.11, 95% CI: 1.1–4.03). 
The mean glucose at the first hour of life was 56.2 mg/dl 
(range 28–105 mg/dl). A trend towards a higher incidence 
of normoglycaemia (>40 mg/dl) was recorded for the longer 
duration of delivery room breastfeeding subgroup (OR: 
1.923 95% CI: 0.984-3.76) [66]. However, the duration of 
delivery room breastfeeding did not influence the rate of 
hypoglycemia. In contrast to this findings, Chertok et al. 
[67] found that breastfed infants had a significantly higher 
mean BGL (3.20 mmol/l) compared to those who were 
formula fed (2.68 mmol/l). One reason for the different 
results could arise from the definition of hypoglycemia. 
In Garcia-Patterson et al. [57] hypoglycemia was defined 
as “normal” (≥ 2.6 mmol/l), “mild hypoglycemia” (2.2–
2.5 mmol/l), “moderate hypoglycemia” (1.7–2.1 mmol/l) 
and “severe hypoglycemia” (1.7 mmol/l). While Chertok 
et al. [67] defined hypoglycemia as BGL<1.93 mmol/l 
and borderline hypoglycemia was 1.93–2.48 mmol/l. In 
addition to differences in measurement, the difference in 
adjusting factors may have contributed to the apparent 
contrast in the results.  
Ramos et al. [15] assessed factors associated with 
hypoglycemia in a cohort of pregnancies with T2D and 
GDM. The incidence of hypoglycemia in this study was 
18% (44/242). The frequency of hypoglycemia between 
the glyburide and insulin-treated pregnancies did not differ 
significantly (23% vs. 27%). Maternal age ≥ 35 years 
(OR: 2.78, 95% CI: 1.13–6.85) and Ponderal Index (OR: 
5.59 95% CI: 1.34–23.25), a measure of fetal adiposity, 
significantly predicted hypoglycemia. Similarly, Majeed 
et al. [44] investigated if maternal glycated hemoglobin 
(HbA1c) was a good predictor of hypoglycemia. As 
hypothesized HbA1c in late pregnancy, between 36 and 38 
weeks of gestation, significantly predicted hypoglycemia 
in the newborn, giving an area under the ROC curve 
of 0.99 with a 95% CI of 0.992 to 1. A ROC curve 
determined the optimal cut-off point for maternal HbA1c 
level in predicting hypoglycemia, was 51 mmol/l (6.8%). 
Sarkar et al. (2003) 
[42]
The incidence of hypoglycemia was 4.3% in the GMD-A1 group compared to the control, 4.4%. 
Neonatal morbidity in infants born to GDM-A1 women is similar to that seen in infants of non-
diabetic women. Unlike infants of insulin-dependent diabetic and insulin requiring GDM women, 
infants born to GDM-A1 women at 36 weeks of gestation or more were not at increased risk of 
developing hypoglycemia, hypocalcemia, hypomagnesemia, polycythemia, hyperbilirubinemia, 
birth trauma or birth asphyxia. Infants born at 36 weeks or more gestation to class A1 GDM 
women can be managed like any other normal full-term infant born to a non-diabetic woman. 
Taylor et al. (2002) 
[61]
Hypoglycemia correlates with maternal hyperglycemia in labor, not with HbA1c during pregnancy. 
Blood glucose was less than 2.5 mmol/l in 50 neonates and was less than 2.0 mmol/l in 18 neonates. 
Maternal blood glucose control in pregnancy had no bearing on the incidence of NH, but maternal 
blood glucose during labor influenced neonatal blood glucose if over 8 mmol/l. 
Tundidor et al. 
(2012) [62]
Male sex was an independent predictor of neonatal hypoglycemia (OR 2.13) and CS (OR 1.48). 
As to neonatal hypoglycaemia, intravenous glucose was required in 16.7% of infants (7.4% in 
female vs. 24.2% in male fetuses; NS). The increased risk of neonatal hypoglycemia in male 
fetuses of mothers with GDM is also the most relevant result in terms of clinical practice, advising 
an increased awareness of neonatal hypoglycemia in these new-borns.
VanHaltren et al. 
(2013)
Hypoglycaemic episodes occurred in 109 (33.4%) infants. Macrosomia was present in 15% of 
the infants. Maternal diabetes Type, HbA1c, prematurity, macrosomia and temperature instability 
were identified as risk factors for neonatal hypoglycaemic.
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However, various studies gave mixed results regarding the 
association between maternal HbA1c and hypoglycemia. 
Using logistic regression Kline and Edwards also found 
that a third trimester HbA1c of >6.5% (47.54 mmol/l) 
had a stronger association with neonatal hypoglycemia 
requiring intervention when compared to maternal 
delivery BGLs (OR: 3.89, 95% CI: 1.42-10.68). However, 
Taylor et al. [62] found that hypoglycemia correlates with 
maternal hyperglycemia in labor, not with HbA1c during 
pregnancy. They found that maternal blood glucose during 
labor influenced neonatal blood glucose if over 8 mmol/l. 
Discussion 
Neonatal hypoglycemia is the most common metabolic 
abnormality in newborn infants due to the inability to 
maintain glucose homeostasis [1,12]. To date, the full 
extent of various risk factors of hypoglycemia in infants 
of diabetic mothers are not known. Our findings are the 
result of a systematic search for all relevant studies on 
hypoglycemia in diabetic mothers and critical appraisal of 
methodologies and study quality assessment. 
We found few prospective studies that carefully examined 
the clinical and demographic risk factors of hypoglycemia 
among neonates. However, the majority of studies identified 
in our literature review were observational of retrospective 
design that used existing institutional databases. As a 
result, after assessing studies’ strengths, weaknesses and 
generalizability using the STROBE Statement, the overall 
quality of evidence was low [68]. The clinical risk factors 
in these studies can be broadly classified into two: infant-
related and mother-related clinical risk factors. The infant-
related significant risk factors identified in these study were 
SGA, LGA, macrosomia, prematurity, lower cord blood 
glucose, Ponderal Index and male sex [15,35,43,56,58,63]. 
On the other hand, mother-related significant risk factor 
of hypoglycemia includes maternal hyperglycemia, ethnic 
origin, diabetes diagnosed prior to 28 weeks of gestation, 
pre-pregnancy BMI ≥ 25 kg/m2, hyperglycemia, blood 
glucose, maternal diabetes type and material HbA1c 
[22,27,44,57,61,63]. Although several other risk factors 
were considered in these studies, the statistically significant 
risk factors are important for understanding the clinical 
management of the study population and future studies 
using multilevel design of risk assessment. Irrespective of 
diabetes type, it appears that infants of diabetic mothers 
have a higher risk of hypoglycemia compared to those 
born to normal mothers [42,55].
Overall, the results of the individual studies assessed 
various risk factors. However, a consistent pattern of risks 
of hypoglycemia among infants of diabetic mothers was not 
identified which may be the result of several factors. First, 
as the definition of clinical significance of hypoglycemia 
remains one of the contentious issues in contemporary 
neonatology, individual studies included in this review 
used different definitions of hypoglycemia ranging from 
<1.1 mmol/l to <2.8 mmol/l. The variation in the definition 
of hypoglycemia has an important implication on the 
predictive power of individual studies. The standard of 
care in most neonatology units involves close surveillance 
if the plasma glucose concentration is less than 2.2 mmol/l 
[69-77]. Second, mothers included in this review were 
diagnosed with diabetes. However, there was variation 
in the type of diabetes. The review included mothers 
with T1D, T2D, GDM, which are commonly recognized 
[49,50]. Sarkar et al. [42] pointed out that the incidence 
of hypoglycemia and the associated risk factors may vary 
based on the specific type of diabetes. Third, about 65% of 
studies identified in the review were observational studies 
that used existing data collected as part of standard of care 
(i.e., not for research purpose). In this regard, collecting 
prospective data or using national registry data may have 
provided more consistent predictors of hypoglycemia. 
Fourth, individual studies used different measurements 
of blood glucose. Although, more than 76% of studies 
specified their blood glucose measurement methods, 
variations in these methods, measurement time, and place 
(laboratory vs. bedside) may have affected the accuracy of 
blood glucose measurement. Similarly, a recent systematic 
review identified 18 studies that examined neonatal 
hypoglycemia and its relationship to neurodevelopmental 
outcomes found a higher rate of heterogeneity among 
studies [78]. In our study, we also found major clinical 
heterogeneity in patient characteristics, measurement of 
hypoglycemia, design, and quality. As a result, statistical 
pooling of result to conduct a meta-analysis was not 
carried out. 
Overall, the majority of the studies in our review were 
observational in design, which makes an inference of 
causality difficult, especially when different protocols were 
followed to measure, handle and analyze blood sampling. 
Less than a third of the studies used a prospective design 
to minimize errors associated with measuring exposure. 
Key limitations include the possibility of publication bias. 
As our review found both positive and negative results, 
publication bias may not be a great concern for the current 
review. The fact that our systematic review included 
studies only written in English may be another limitation. 
However, previous studies have shown that language 
restrictions in systematic reviews have minimal effect 
on the results [79,80]. The fact that 47 percent of studies 
did not report a laboratory measurement for confirmation 
of neonatal hypoglycemia and the lack of generally 
acceptable definition of neonatal hypoglycemia may have 
affected the proper dictation of the outcome. However, 
as all studies followed a written clinical protocol in the 
management of hypoglycemia, the bias associated with 
laboratory confirmation is not differential.
Conclusion and Recommendations for Future 
Research
In summary, there is evidence supporting the clinical 
importance of giving attention to infants of diabetic 
mothers. Irrespective of the type of diabetes, infants 
of diabetic mothers have a higher risk of developing 
hypoglycemia compared to those born to mothers 
without diabetes. However, the studies included in this 
review mainly focused on the clinical characteristics 
of the infants and mothers. Future research should also 
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focus on identifying other factors that may increase the 
risk of neonatal hypoglycemia such as neighborhood 
and institutional characteristics including, genetics, 
socioeconomic status, and disparities in health care 
delivery. This can be accomplished by taking the following 
three steps:
1. Defining neonatal hypoglycemia using the multiple 
clinical cut-of-points to identify the most salient 
risk factors. 
2. Using large population based national registry 
database that is developed to facilitate the conduct 
of analyses pertaining to neonatal complications 
will help to obtain adequate comparison groups. 
Most of the studies included in this review used 
hospital based data that is generated as part of 
standard of care.
3. Stratifying the mother’s diabetes type to identify 
the significance of T1D, T2D and GDM on the risk 
of developing neonatal hypoglycemia. 
4. Using multilevel statistical models to incorporate 
the individual and contextual characteristics of 
infants and mothers.
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